Aushon BioSystems
Billerica
About Aushon BioSystems
Aushon BioSystems provides comprehensive and robust protein biomarker assay development, detection and analysis through an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance, quality and reliability to accelerate pre-clinical and clinical biomarker research. With a growing menu of more than 300 biomarkers in key therapeutic areas, and advanced microarray printing technology, their broad suite of products and services offers a unique and complete solution for their customers – global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries. They trust us to provide the most reliable protein biomarker data available, in the least amount of time, to lower their costs and improve research productivity.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $100K – $500K
- Total funding: $37.4M
- Last round: Series Unknown (Jul 2016)
- Website: aushon.com
- Phone: (978)436-6400
Industries & Categories
Biotechnology, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/aushon-biosystems-3145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.